2020
DOI: 10.1080/01612840.2020.1719248
|View full text |Cite
|
Sign up to set email alerts
|

Terminology Preferences in Mental Health

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…While training for any pharmacy-based service is important, mental health training is vital for LLD screening, due to the public stigma regarding mental illness experienced by older adults [ 29 ]. Mental health training educates pharmacists on how to use non-stigmatising language when discussing mental health with consumers [ 30 ], which has been shown to reduce stigma [ 31 ]. Mental health training may also increase pharmacists’ knowledge about mental illnesses, thereby better equipping pharmacists to identify at-risk individuals [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…While training for any pharmacy-based service is important, mental health training is vital for LLD screening, due to the public stigma regarding mental illness experienced by older adults [ 29 ]. Mental health training educates pharmacists on how to use non-stigmatising language when discussing mental health with consumers [ 30 ], which has been shown to reduce stigma [ 31 ]. Mental health training may also increase pharmacists’ knowledge about mental illnesses, thereby better equipping pharmacists to identify at-risk individuals [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…MI is defined as diagnosable mental, behavioural, or emotional disorders resulting in substantial impairment of social, emotional, and occupational functioning (Center for Behavioral Health Statistics & Quality 2018) and each disorder varies in severity (RANZCP 2016). For the purpose of this review, and consistent with the language of Australian mental health policy, the term 'consumer' will be used to reference any person diagnosed with a clinically defined high or low prevalence disorder MI (Lyon & Mortimer-Jones 2020). Moreover, reflecting the inclusivity of differing perspectives regarding the diagnosis of MI in policy and for consumers, this review will collectively refer to all people diagnosed with a MI rather than a specific diagnosis (Perkins et al 2018).…”
Section: Introductionmentioning
confidence: 99%